JUST CURIOUS ABOUT PEPTIDES? START HERE.

You heard about peptides. Here's what they actually are.

Honest, plain-English answers about the peptides everyone's been talking about. No sales. No hype.

Independent · No products sold · No vendor links
The bigger picture

Why everyone's suddenly talking about peptides

Peptides went from a niche corner of research chemistry to a mainstream conversation in about three years. Here's what's been driving it, each one tied to a real story, and a page that explains it without the hype.

GLP-1s in the news

Ozempic, Mounjaro, Zepbound

Weight-loss drugs that actually moved the needle changed the conversation about obesity overnight, and pulled the rest of peptide science into the spotlight with them.

See the GLP-1 hub →
Athletes and recovery

Renner, Rogan, the "Wolverine stack"

High-profile athletes started naming recovery peptides on podcasts, and a wave of patients with stubborn injuries started asking about them. BPC-157 is the centerpiece.

Read the BPC-157 explainer →
Longevity goes mainstream

Mitochondria, telomeres, healthspan

Billion-dollar longevity labs and Bryan Johnson-style protocols put GHK-Cu, MOTS-c, Epithalon, and SS-31 in front of a much wider audience.

Explore longevity peptides →
Gut and tissue repair

Why BPC-157 keeps coming up

As gut-inflammation research has grown, peptides studied for gut-lining repair and inflammation became a natural focal point for people exploring options beyond conventional treatment.

Read the BPC-157 explainer →
Sleep and focus

DSIP, Semax, Selank

Sleep trackers turned deep sleep into a measurable goal. Peptides studied for slow-wave sleep, calm focus, and steadier mood entered the conversation naturally.

See the sleep section →
Skin and aesthetics

GHK-Cu and copper peptides

Of the peptides being studied for skin and aesthetics, GHK-Cu has by far the longest research history and the broadest interest from cosmetic science.

Read the GHK-Cu explainer →
The policy conversation

RFK Jr., the FDA, and Category 2

HHS Secretary Robert F. Kennedy Jr. has publicly pushed for compounding access. In April 2026 the FDA agreed to convene an advisory panel to review seven peptides, including BPC-157.

Read the policy explainer →

What are you curious about?

Pick the goal that's on your mind. We'll show you which peptides researchers most often study for it, and what the honest read is.

As covered in
Peptides 101, in 60 seconds

What is a peptide, really?

Your body makes peptides every second. They're tiny chains of amino acids, basically little messengers that tell your cells what to do. Some peptides help you sleep. Some help you heal. Some help you regulate appetite. The peptides being researched today are mostly synthetic versions of those natural messengers.

That's the whole concept. The rest is which one, for what, and what the evidence actually says.

Tell me more →

Why this site exists

This site doesn't sell peptides. There are no products, no vendor links, and no affiliate codes anywhere on it. It exists to explain this stuff honestly, in plain English, with the science in the open, and without anyone trying to sell you anything at the end of the page.

Every page on this site flags what's actually proven, what's still being studied, and what's been hyped further than the evidence supports. That's the whole job.

For educational and research purposes only. This is not medical advice. Most peptides discussed on this site are not FDA-approved for human therapeutic use. Consult a licensed healthcare provider before considering any peptide. PeptideLibraryHub does not sell peptides or link to vendors. Read the full disclaimers →